GleamWall
中文EN

CRLBF Cresco Labs Inc. Annual reports only

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1832928 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-9.5%
TTM net income YoY-81.9%
TTM EPS YoY-72.7%
Revenue 3-yr CAGR-8.0%
Net income 3-yr CAGR—

Margins

Gross margin49.5%
Operating margin-4.3%
Net margin-20.6%
FCF margin5.8%
EBITDA margin3.2%

Returns

ROE-33.2%
ROA-10.6%
ROIC (approx.)-2.9%
Asset turnover0.51x

Leverage & solvency

Liabilities / assets78.9%
Debt / equity1.23x
Current ratio2.59x
Interest coverage-0.67x

Cash quality & payout

Operating cash flow / net income-0.54x
Accruals ratio-16.3%
Payout ratio—
Capex / revenue5.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$655.85M$724.34M
Cost of revenue$331.28M$359.89M
Gross profit$324.57M$364.45M
SG&A expense$247.45M$254.84M
Operating income-$27.99M$107.29M
Interest expense$41.75M$37.93M
Pretax income-$95.42M-$10.62M
Income tax$44.62M$49.87M
Net income-$135.41M-$74.44M
EBITDA$20.73M$166.39M
EPS (basic)-0.38-0.22
EPS (diluted)-0.38-0.22
Weighted avg. shares (diluted)355.01M345.47M
Balance sheet
Cash & equivalents$57.90M$137.56M
Receivables$37.89M$51.56M
Inventory$98.67M$83.34M
Current assets$259.27M$294.26M
PP&E, net$327.19M$344.85M
Goodwill$208.17M$283.48M
Intangibles$275.34M$293.99M
Total assets$1.20B$1.36B
Current liabilities$100.18M$94.34M
Short-term debt$3.30M$2.61M
Long-term debt$417.10M$460.75M
Total debt$420.39M$463.36M
Total liabilities$944.80M$967.18M
Shareholders' equity$340.45M$474.85M
Net debt$362.49M$325.80M
Cash flow statement
Operating cash flow$72.89M$132.48M
Capital expenditure$35.14M$19.49M
Free cash flow$37.75M$112.99M
Investing cash flow-$40.70M-$25.23M
Financing cash flow-$82.09M-$71.48M
Depreciation & amortization$48.71M$59.10M
Stock-based compensation$11.23M$14.16M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.